These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10463586)

  • 21. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.
    Grossmann V; Kohlmann A; Zenger M; Schindela S; Eder C; Weissmann S; Schnittger S; Kern W; Müller MC; Hochhaus A; Haferlach T; Haferlach C
    Leukemia; 2011 Mar; 25(3):557-60. PubMed ID: 21274004
    [No Abstract]   [Full Text] [Related]  

  • 22. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of FLT3 gene and FLT3/ITD gene mutation in chronic myeloid leukemia and its significance].
    Xu B; Tian H; Zhou SY
    Ai Zheng; 2004 Oct; 23(10):1218-21. PubMed ID: 15473940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
    Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
    Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of FHIT expression in chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; O'Brien S; Manshouri T; Cortes J; Giles F; Rios MB; Croce CM; Albitar M
    Clin Cancer Res; 1999 Dec; 5(12):4059-64. PubMed ID: 10632340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
    Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
    Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
    Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mutations of the p53 gene in hematologic neoplasms].
    Mori N; Mizoguchi H
    Nihon Rinsho; 1992 Jun; 50(6):1353-7. PubMed ID: 1518157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
    Yin CC; Medeiros LJ; Glassman AB; Lin P
    Am J Clin Pathol; 2004 Jun; 121(6):836-42. PubMed ID: 15198355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model mice for BCR/ABL-positive leukemias.
    Honda H; Hirai H
    Blood Cells Mol Dis; 2001; 27(1):265-78. PubMed ID: 11358387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
    Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
    Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
    Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
    Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
    Zhang SJ; Shi JY; Li JY
    Leuk Res; 2009 Aug; 33(8):1141-3. PubMed ID: 19304323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ikaros expression in human hematopoietic lineages.
    Nakayama H; Ishimaru F; Katayama Y; Nakase K; Sezaki N; Takenaka K; Shinagawa K; Ikeda K; Niiya K; Harada M
    Exp Hematol; 2000 Nov; 28(11):1232-8. PubMed ID: 11063871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
    Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
    Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic myelogenous leukemia molecular signature.
    Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T
    Oncogene; 2003 Jun; 22(25):3952-63. PubMed ID: 12813469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of bcl-2 gene in the evolution of chronic myelogenous leukemia to blast crisis and its implication].
    Sui X; Su L; Chu J
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):27-9. PubMed ID: 11498840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 gene alterations in human hematological malignancies: a review.
    Soussi T; Jonveaux P
    Nouv Rev Fr Hematol (1978); 1991; 33(6):477-80. PubMed ID: 1818301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tiazofurin effects on IMP-dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis.
    Wright DG; Boosalis MS; Waraska K; Oshry LJ; Weintraub LR; Vosburgh E
    Anticancer Res; 1996; 16(6A):3349-51. PubMed ID: 9042310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.